Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 153
Filter
1.
Cureus ; 13(8): e16992, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34377617

ABSTRACT

Enteropathy-associated T-cell lymphoma (EATL) is a tumor of intraepithelial T-lymphocytes arising in the small intestine. Based on the genetic profile, immunohistochemistry, and histology, EATL is divided into two subtypes. EATL type I occurs in individuals with celiac disease (CD) while EATL type II is a sporadic form that occurs in individuals without CD. Intensive chemotherapy and surgery are the mainstay treatment. However, despite the currently available treatment options, the five-year survival rate is only 9%. EATL presents as abdominal pain, nausea, or slow gastrointestinal bleeding. Severe bleeding leading to hemodynamic instability is rarely known in EATL. Therefore, we present a unique case of EATL who presented with acute and severe gastrointestinal bleeding with no prior history of CD.

2.
Cureus ; 12(12): e12307, 2020 Dec 26.
Article in English | MEDLINE | ID: mdl-33520506

ABSTRACT

Mechanical obstruction of the colon is rare with necrotizing pancreatitis but is associated with high morbidity and mortality. However, pancreatic ileus, colonic necrosis, and pancreatic colonic fistulae with necrotizing pancreatitis are well known. The anatomic proximity of the pancreas to the transverse colon becomes clinically relevant when a patient with pancreatitis demonstrates a localized ileus of the transverse colon (an old term "the colon cut-off sign"), even when the disease is mild, or lower gastrointestinal bleeding secondary to necrosis of the segment in severe acute pancreatitis. We present the case of a 25-year-old female with choledocholithiasis who presented with severe abdominal pain and was found to have recurrent large bowel obstruction secondary to walled-off pancreatic necrosis. Bowel obstruction is a rare complication of walled-off necrosis, but clinicians should be aware of it due to significantly increased mortality rates. Recurrent bowel obstructions are rarely known in necrotizing pancreatitis and may warrant a bowel resection either electively or acutely. Walled-off necrosis does not respond to typical treatment of symptomatic pseudocysts, which includes endoscopic cystogastrostomy or percutaneous drainage with small-bore catheters. Endoscopic or surgical necrosectomy is necessary for the resolution of walled-off necrosis to evacuate the non-liquefied components.

3.
J Med Case Rep ; 10(1): 235, 2016 Aug 24.
Article in English | MEDLINE | ID: mdl-27557756

ABSTRACT

BACKGROUND: Rhabdomyolysis secondary to quinolones is not frequent. There are scarce reports in the literature associating rhabdomyolysis to levofloxacin. We describe a case of levofloxacin-induced rhabdomyolysis. CASE PRESENTATION: A 52-year-old African-American man presented with muscle tightness after taking three doses of levofloxacin. He had elevated creatine kinase without acute kidney injury. His symptoms resolved after discontinuation of levofloxacin and supportive care. CONCLUSIONS: It is fascinating that our patient has a prior history of rhabdomyolysis, likely from levofloxacin. Our case highlights the need to be mindful of this potentially life-threatening complication of levofloxacin.


Subject(s)
Anti-Bacterial Agents/adverse effects , Levofloxacin/adverse effects , Rhabdomyolysis/chemically induced , Anti-Bacterial Agents/administration & dosage , Creatine Kinase/blood , Creatine Kinase/metabolism , Humans , Levofloxacin/administration & dosage , Male , Middle Aged , Muscle Fatigue , Respiratory Tract Infections/drug therapy , Treatment Outcome
4.
Gastroenterol Res Pract ; 2015: 387891, 2015.
Article in English | MEDLINE | ID: mdl-26170832

ABSTRACT

Musculoskeletal manifestations are the most common extraintestinal manifestations in inflammatory bowel diseases. Some appendicular manifestations are independent of gut inflammation and are treated with standard anti-inflammatory strategies. On the other hand, axial involvement is linked to gut inflammatory activity; hence, there is a considerable amount of treatment overlap. Biological therapies have revolutionized management of inflammatory bowel diseases as well as of associated articular manifestations. Newer mechanisms driving gut associated arthropathy have surfaced in the past decade and have enhanced our interests in novel treatment targets. Introduction of biosimilar molecules is expected in the US market in the near future and will provide an opportunity for considerable cost savings on healthcare. A multidisciplinary approach involving a gastroenterologist, rheumatologist, and physical therapist is ideal for these patients.

6.
J Clin Gastroenterol ; 48(3): 195-203, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24172179

ABSTRACT

Hypertriglyceridemia (HTG) is a well-established but underestimated cause of acute pancreatitis and recurrent acute pancreatitis. The clinical presentation of HTG-induced pancreatitis (HTG pancreatitis) is similar to other causes. Pancreatitis secondary to HTG is typically seen in the presence of one or more secondary factors (uncontrolled diabetes, alcoholism, medications, pregnancy) in a patient with an underlying common genetic abnormality of lipoprotein metabolism (familial combined hyperlipidemia or familial HTG). Less commonly, a patient with rare genetic abnormality (familial chylomicronemic syndrome) with or without an additional secondary factor is encountered. The risk of acute pancreatitis in patients with serum triglycerides >1000 and >2000 mg/dL is ∼ 5% and 10% to 20%, respectively. It is not clear whether HTG pancreatitis is more severe than when it is due to other causes. Clinical management of HTG pancreatitis is similar to that of other causes. Insulin infusion in diabetic patients with HTG can rapidly reduce triglyceride (TG) levels. Use of apheresis is still experimental and better designed studies are needed to clarify its role in the management of HTG pancreatitis. Diet, lifestyle changes, and control of secondary factors are key to the treatment, and medications are useful adjuncts to the long-term management of TG levels. Control of TG levels to 500 mg/dL or less can effectively prevent recurrences of pancreatitis.


Subject(s)
Hypertriglyceridemia/complications , Pancreatitis/etiology , Acute Disease , Biomarkers/blood , Genetic Predisposition to Disease , Humans , Hypertriglyceridemia/blood , Hypertriglyceridemia/diagnosis , Hypertriglyceridemia/genetics , Hypertriglyceridemia/therapy , Pancreatitis/blood , Pancreatitis/diagnosis , Pancreatitis/genetics , Pancreatitis/therapy , Risk Factors , Secondary Prevention , Treatment Outcome , Triglycerides/blood , Up-Regulation
8.
Indian J Med Res ; 138(4): 461-91, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24434254

ABSTRACT

Several reviews and meta-analyses have demonstrated the incontrovertible benefits of statin therapy in patients with cardiovascular disease (CVD). But the role for statins in primary prevention remained unclear. The updated 2013 Cochrane review has put to rest all lingering doubts about the overwhelming benefits of long-term statin therapy in primary prevention by conclusively demonstrating highly significant reductions in all-cause mortality, major adverse cardiovascular events (MACE) and the need for coronary artery revascularization procedures (CARPs). More importantly, these benefits of statin therapy are similar at all levels of CVD risk, including subjects at low (<1% per year) risk of a MACE. In addition to preventing myocardial infarction (MI), stroke, and death, primary prevention with statins is also highly effective in delaying and avoiding expensive CARPs such as angioplasties, stents, and bypass surgeries. There is no evidence of any serious harm or threat to life caused by statin therapy, though several adverse effects that affect the quality of life, especially diabetes mellitus (DM) have been reported. Asian Indians have the highest risk of premature coronary artery disease (CAD) and diabetes. When compared with Whites, Asian Indians have double the risk of CAD and triple the risk of DM, when adjusted for traditional risk factors for these diseases. Available evidence supports the use of statin therapy for primary prevention in Asian Indians at a younger age and with lower targets for low-density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein (non-HDL-C), than those currently recommended for Americans and Europeans. Early and aggressive statin therapy offers the greatest potential for reducing the continuing epidemic of CAD among Indians.


Subject(s)
Coronary Artery Disease/drug therapy , Diabetes Mellitus/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Muscular Diseases/pathology , Apolipoproteins B/metabolism , Asian People , Cholesterol, HDL/metabolism , Cholesterol, VLDL/metabolism , Coronary Artery Disease/complications , Coronary Artery Disease/physiopathology , Diabetes Mellitus/pathology , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , India , Muscular Diseases/complications , Muscular Diseases/drug therapy , Risk Factors
9.
J Clin Gastroenterol ; 45(7): 614-25, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21750432

ABSTRACT

The advent of computed tomographic scan with its wide use in the evaluation of acute pancreatitis has opened up a new topic in pancreatology i.e. fluid collections. Fluid collections in and around the pancreas occur often in acute pancreatitis and were defined by the Atlanta Symposium on Acute Pancreatitis in 1992. Two decades since the Atlanta Conference additional experience has brought to light the inadequacy and poor understanding of the terms used by different specialists involved in the care of patients with acute pancreatitis when interpreting imaging modalities and the need for a uniformly used classification system. The deficiencies of the Atlanta definitions and advances in medicine have led to a proposed revision of the Atlanta classification promulgated by the Acute Pancreatitis Classification Working Group. The newly used terms "acute peripancreatic fluid collections," "pancreatic pseudocyst," "postnecrotic pancreatic/peripancreatic fluid collections," and "walled-off pancreatic necrosis" are to be clearly understood in the interpretation of imaging studies. The current treatment methods for fluid collections are diverse and depend on accurate interpretations of radiologic tests. Management options include conservative treatment, percutaneous catheter drainage, open and laparoscopic surgery, and endoscopic drainage. The choice of treatment depends on a correct diagnosis of the type of fluid collection. In this study we have attempted to clarify the management and clinical features of different types of fluid collections as they have been initially defined under the 1992 Atlanta Classification and revised by the Working Group's proposed categorization.


Subject(s)
Pancreas/diagnostic imaging , Pancreatic Pseudocyst/diagnostic imaging , Pancreatitis, Acute Necrotizing/diagnostic imaging , Pancreatitis/classification , Pancreatitis/diagnostic imaging , Acute Disease , Body Fluids/diagnostic imaging , Drainage/methods , Humans , Pancreatic Pseudocyst/therapy , Pancreatitis/diagnosis , Pancreatitis/therapy , Pancreatitis, Acute Necrotizing/therapy , Radiography
10.
J Crit Care ; 26(2): 225.e11-8, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21185146

ABSTRACT

Acute pancreatitis (AP) is an acute inflammatory process of the pancreas that is associated with variable involvement of pancreatic/peripancreatic tissue and one or more organ systems in varying degrees. Among the multiple organ system dysfunctions in severe AP, cardiovascular and/or pulmonary manifestations are frequent. The cardiovascular system may be affected alone or with other organ systems in all stages of AP. Abnormalities of cardiac rhythm, contractility, and vasomotor tone of peripheral vessels are common cardiovascular manifestations. The pathogenetic factors of cardiac manifestations include hypovolemia and metabolic disturbances (eg, hyperkalemia, hypomagnesemia, and hypophosphatemia). Clinically, patients present with hypotension, tachycardia, and signs of systemic inflammatory response syndrome (high cardiac index, significant pulmonary shunting, decreased systemic vascular resistance, and decreased myocardial contractility). Approximately 50% of patients with AP have electrocardiographic changes, most commonly T-wave flattening and ST-segment depression. Many of the cardiac manifestations in AP are reversible with appropriate management. In AP, early onset of either multi-organ dysfunction or a sustained single-organ dysfunction is associated with poor outcome. This review highlights cardiac manifestations of AP relevant to clinical practice.


Subject(s)
Cardiovascular Diseases/physiopathology , Pancreatitis/physiopathology , Acute Disease , Cardiac Output , Cytokines/metabolism , Electrocardiography , Humans , Hypovolemia/physiopathology
12.
J Clin Gastroenterol ; 44(4): 246-53, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20087199

ABSTRACT

Crohn's disease and ulcerative colitis, together popularly known as inflammatory bowel disease (IBD), are characterized by a number of extraintestinal manifestations. Although infrequent, acute pancreatitis, and less often chronic pancreatitis, may occur as a result of the disease itself or secondary to the medications used in the treatment. The increased incidence of acute pancreatitis in Crohn's disease can be explained based on the high predisposition to cholesterol as well as pigment stones as a result of ileal disease, anatomic abnormalities of the duodenum, immunologic disturbances associated with IBD, and, above all, to the side effects of many medications used in the treatment. Sulfasalazine, 5-aminosalicylic acid, azathioprine, and 6-mercaptopurine are well known to cause acute pancreatitis as a result of a possible idiosyncratic mechanism. Crohn's disease and ulcerative colitis share many clinical manifestations and treatment modalities. Nonspecific elevations of serum pancreatic enzymes in IBD make it difficult to avoid over diagnosis of acute pancreatitis, particularly in patients with Crohn's disease who suffer from abdominal pain often. The IBD-pancreas association is further reflected in many reports of exocrine as well as endocrine pancreatic insufficiency.


Subject(s)
Immunosuppressive Agents/adverse effects , Inflammatory Bowel Diseases/complications , Pancreatitis , Acute Disease , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Azathioprine/adverse effects , Azathioprine/therapeutic use , Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Crohn Disease/complications , Crohn Disease/drug therapy , Humans , Immunosuppressive Agents/therapeutic use , Incidence , Inflammatory Bowel Diseases/drug therapy , Mercaptopurine/adverse effects , Mercaptopurine/therapeutic use , Mesalamine/adverse effects , Mesalamine/therapeutic use , Pancreatitis/diagnosis , Pancreatitis/epidemiology , Pancreatitis/etiology , Pancreatitis/physiopathology , Sulfasalazine/adverse effects , Sulfasalazine/therapeutic use
13.
J Clin Gastroenterol ; 43(7): 627-31, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19623687

ABSTRACT

INTRODUCTION: Anemia although a frequent problem in all age groups, is an important cause of morbidity and mortality in the elderly. Despite standard endoscopic diagnostic evaluations with esophagogastroduodenoscopy (EGD) and colonoscopy, up to 30% of patients with iron deficiency anemia (IDA) are without a definitive diagnosis. Obscure gastrointestinal bleeding (OGIB) (occult or overt) from the small bowel, could be the source of IDA in patients with normal EGD and colonoscopy. Wireless capsule endoscopy (WCE), a relatively new diagnostic modality helps in the detection of small bowel mucosal abnormalities. AIM: The aim of this study is to report on the diagnostic yield (DY) of WCE for IDA with or without OGIB in older adults and its comparison with younger age groups. MATERIALS AND METHODS: In this retrospective study, data is based on652 consecutive WCE performed during a 5-year period (2002 to 2007). RESULTS: Total number ofWCE=652 (males=311, females=341). IDA was the indication for WCE in 424 of 652 cases (65%). Most common finding observed by WCE in patients with IDA without OGIB: group 1 (age<50 y)=small bowel erosion (19%) and ulceration (19%), group 2 (age 50 to 64 y)=small bowel erosion (33%), group 3 (age 65 to 85 y, older adults)=small bowel erosion (30%), and group 4 (age>85 y, the oldest old)=small bowel erosion (38%). Most common finding observed by WCE in patients with IDA with OGIB: group 1=small bowel ulceration (19%), group 2=small bowel erosion (26%), group 3=small bowel erosion (38%), and group 4=angiodysplasia (55%). DY of WCE for IDA without OGIB: group 1=50%, group 2=52%, group 3=56%, and group 4=69%. DY of WCE for IDA with OGIB: group 1=38%, group 2=58%, group 3=63%, and group 4=73%. Active bleeding in the small bowel was seen in 48 of 424 (11%) patients with IDA. CONCLUSIONS: WCE, a valuable tool for the visualization of entire small bowel mucosa plays a critical role for the evaluation of IDA in patients with negative EGD and colonoscopy. Small bowel erosions, ulcerations, and angiodysplasia observed by WCE are the most frequent findings in patients with IDA. DY of WCE in the evaluation of IDA progressively increases as age advances.


Subject(s)
Anemia, Iron-Deficiency/diagnosis , Capsule Endoscopy/methods , Gastrointestinal Hemorrhage/diagnosis , Intestinal Mucosa/pathology , Age Factors , Aged , Aged, 80 and over , Anemia, Iron-Deficiency/etiology , Colonoscopy/methods , Endoscopy, Digestive System/methods , Female , Gastrointestinal Hemorrhage/complications , Humans , Male , Middle Aged , Retrospective Studies
15.
J Clin Gastroenterol ; 43(2): 103-10, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19142171

ABSTRACT

Gastrointestinal (GI) symptoms resulting from either prescription medications or over-the-counter drugs are frequently encountered in geriatric practice but often mistaken for symptoms of an organic disease leading to multiple diagnostic studies. The morbidity, mortality, and medical costs associated with drug toxicity, even when restricted to the GI tract, are probably underestimated. The consequences of drug toxicity are quite variable and range from a symptom of mild discomfort (eg, drug-induced diarrhea) at one end of the spectrum, to fatal GI hemorrhage or perforation. Better awareness of the possibility of drug-induced GI tract pathology by primary care physicians improves the recognition of these adverse effects, and ultimately, improves patient care. This review focuses on the most common and well-described drug-related side effects of the GI tract.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Gastrointestinal Diseases/chemically induced , Gastrointestinal Tract/drug effects , Nonprescription Drugs/adverse effects , Prescription Drugs/adverse effects , Aged , Gastrointestinal Diseases/epidemiology , Gastrointestinal Tract/pathology , Humans , Incidence
16.
Diabetes Res Clin Pract ; 84(1): 84-91, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19168251

ABSTRACT

AIM: To estimate prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with glucose intolerance (type 2 diabetes (DM), prediabetes) and metabolic syndrome (MS) in urban south Indians. METHODS: This study was carried out in 541 subjects (response rate 92%) of the original sample of 26,001 subjects in the Chennai Urban Rural Epidemiology Study maintaining the representativeness. Anthropometry and lipid estimations were done in all and oral glucose tolerance test in all, except self-reported diabetic subjects. NAFLD was diagnosed by ultrasonography and MS by modified Adult Treatment Panel III (ATP III) criteria. DM, impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) were defined using WHO consulting group criteria. RESULTS: Overall prevalence of NAFLD was 32% (173/541 subjects) (men: 35.1%, women: 29.1%, p=0.140). Prevalence of most cardio-metabolic risk factors was significantly higher in NAFLD subjects. Prevalence of NAFLD (54.5%) was higher in subjects with DM compared to those with prediabetes (IGT or IFG) (33%), isolated IGT (32.4%), isolated IFG (27.3%) and normal glucose tolerance (NGT) (22.5%) (DM vs. prediabetes: p<0.05, DM vs. NGT: p<0.001, prediabetes vs. NGT: p<0.05). Even after adjusting for age, gender and waist circumference, NAFLD was associated with diabetes (OR: 2.9, 95% C.I.: 1.9-4.6, p<0.001) and MS (OR: 2.0, 95% C.I.: 1.3-3.1, p<0.001). CONCLUSION: NAFLD is present in a third of urban Asian Indians and its prevalence increases with increasing severity of glucose intolerance and in MS. This is the first population-based prevalence of NAFLD from south Asia which faces the brunt of the diabetes epidemic.


Subject(s)
Fatty Liver/epidemiology , Fatty Liver/pathology , Glucose Intolerance/epidemiology , Glucose Intolerance/pathology , Metabolic Syndrome/epidemiology , Metabolic Syndrome/pathology , Adult , Fatty Liver/metabolism , Female , Glucose Intolerance/metabolism , Humans , India/epidemiology , Male , Metabolic Syndrome/metabolism , Middle Aged , Prevalence
17.
J Clin Gastroenterol ; 42(9): 980-3, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18596537

ABSTRACT

BACKGROUND: The prevalence of celiac disease (CD) is estimated to be 1% in the US population, yet many cases are undiagnosed. CD might present itself in the older adults (age >60 y) for the first time, solely with iron deficiency anemia (IDA). Recent studies indicate that approximately 20% of newly diagnosed CD patients are older than 60 years. Wireless capsule endoscopy (WCE) identifies small bowel mucosal abnormalities by direct visualization. Incidental findings observed by WCE indicative of CD prompt confirmatory diagnostic tests such as IgA class antitissue transglutaminase antibody and IgA class antiendomysial antibody. AIM: To present the frequency of mucosal abnormalities and their location suggestive of CD observed by WCE, in the older adults with IDA. MATERIALS AND METHODS: In this retrospective study, data is collected from patients who underwent WCE mostly for the evaluation of IDA with or without other symptoms such as obscure gastrointestinal bleeding, abdominal pain, and chronic diarrhea over a period of 5 years (2002 to 2007). RESULTS: Out of 652 cases of WCE, 360 were older adults (age >60 y). Evaluation of IDA was the indication in 279 out of 360 (78%) older adults. Among the 279 older adults with IDA, 7 (2.5%) had mucosal abnormalities suggestive of CD (atrophy, scalloping, mosaicism, layering, and nonspecific ulcerating jejuno-ileitis). Subsequent evaluation with serum antibody testing +/-multiple distal duodenal biopsies confirmed the diagnosis in all patients. Five out of 7 (71%) older adults had normal looking duodenal mucosa on WCE, but had classic abnormalities of CD distally. CONCLUSIONS: (1) Mucosal abnormalities of CD may be seen on WCE for the first time, in the older adults with IDA with no past clinical picture of the disease. (2) Duodenum may be entirely normal by esophagogastroduodenoscopy examination; whereas the proximal and distal intestine may show classic features of CD by WCE.


Subject(s)
Anemia, Iron-Deficiency/etiology , Capsule Endoscopy/methods , Celiac Disease/diagnosis , Intestinal Mucosa/pathology , Abdominal Pain/etiology , Age Factors , Aged , Aged, 80 and over , Celiac Disease/complications , Celiac Disease/epidemiology , Diarrhea/etiology , Female , Gastrointestinal Hemorrhage/etiology , Humans , Intestine, Small/pathology , Male , Middle Aged , Retrospective Studies , United States/epidemiology
18.
World J Gastroenterol ; 14(5): 709-12, 2008 Feb 07.
Article in English | MEDLINE | ID: mdl-18205259

ABSTRACT

AIM: To analyze the prevalence of gastroesophageal reflux disease (GERD) related symptoms in patients with diabetes mellitus (DM) and to find out the relationship between diabetic neuropathy and the prevalence of GERD symptoms. METHODS: In this prospective questionnaire study, 150 consecutive type 2 diabetic patients attending the endocrine clinic were enrolled. A junior physician helped the patients to understand the questions. Patients were asked about the presence of five most frequent symptoms of GERD that included heartburn (at least 1/wk), regurgitation, chest pain, hoarseness of voice and chronic cough. Patients with past medical history of angina, COPD, asthma, cough due to ACEI or preexisting GERD prior to onset of diabetes and apparent psychiatric disorders were excluded from the survey. We further divided the patients into two groups based on presence or absence of peripheral neuropathy. Out of 150 patients, 46 had neuropathy, whereas 104 patients did not have neuropathy. Data are expressed as mean +/- SD, and number of patients in each category and percentage of total patients in that group. Normal distributions between groups were compared with Student t test and the prevalence rates between groups were compared with Chi-square tests for significance. RESULTS: The average duration of diabetes were 12 +/- 9.2 years and the average HbA1c level of this group was 7.7% +/- 2.0%. The mean weight and BMI were 198 +/- 54 lbs. and 32 +/- 7.2 kg/m2. Forty percent (61/150) patients reported having at least one of the symptoms of GERD and thirty percent (45/150) reported having heartburn at least once a week. The prevalence of GERD symptoms is higher in patients with neuropathy than patients without neuropathy (58.7% vs 32.7%, P < 0.01). The prevalence of heartburn, chest pain and chronic cough are also higher in patients with neuropathy than in patients without neuropathy (43.5% vs 24%; 10.9% vs 4.8% and 17.8% vs 6.7% respectively, P < 0.05). CONCLUSION: The prevalence of GERD symptoms in type 2 DM is higher than in the general population. Our data suggest that DM neuropathy may be an important associated factor for developing GERD symptoms.


Subject(s)
Diabetes Mellitus, Type 2/epidemiology , Diabetic Neuropathies/epidemiology , Gastroesophageal Reflux/epidemiology , Adult , Aged , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Prevalence
19.
Case Rep Gastroenterol ; 2(1): 27-32, 2008 Jan 24.
Article in English | MEDLINE | ID: mdl-21490834

ABSTRACT

BACKGROUND/AIM: Pancreatic sepsis secondary to infected necrosis, pseudocyst, or pancreatic abscess is a well-known clinical entity. Acute suppuration of the pancreatic duct (ASPD) in the setting of chronic calcific pancreatitis and pancreatic ductal obstruction with septicemia is a rare complication that is seldom reported. It is our aim to report a case of ASPD with Klebsiella ornithinolytica, in the absence of pancreatic abscess or infected necrosis. CASE REPORT: A 46-year-old Asian-Indian man with chronic tropical pancreatitis who was admitted with recurrent epigastric pain that rapidly evolved into septic shock. A CT scan of abdomen revealed a dilated pancreatic duct with a large calculus. Broad-spectrum antibiotics, vasopressors and activated recombinant protein C were initiated. Emergency ERCP showed the papilla of Vater spontaneously expelling pus. Probing and stenting was instantly performed until pus drainage ceased. Repeat CT scan confirmed the absence of pancreatic necrosis or fluid collection, and decreasing ductal dilatation. Dramatic clinical improvement was observed within 36 hours after intervention. Blood cultures grew Klebsiella ornithinolytica. The patient completed his antibiotic course and was discharged. CONCLUSION: ASPD without pancreatic abscess or infected necrosis is an exceptional clinical entity that should be included in the differential diagnosis of pancreatic sepsis. A chronically diseased pancreas and diabetes may have predisposed to the uncommon pathogen. The presence of intraductal pancreatic stones obstructing outflow played a major role in promoting bacterial growth, suppuration and septicemia. Immediate drainage of the pancreatic duct with endoscopic intervention is critical and mandatory.

20.
World J Gastroenterol ; 12(43): 7055-7, 2006 Nov 21.
Article in English | MEDLINE | ID: mdl-17109506

ABSTRACT

Acute pancreatitis (AP) secondary to drugs is un-common, with an incidence ranging from 0.3% to 2.0% of AP cases. Drug-induced AP due to statins is rare, and only 12 cases have thus far been reported. In this case report, we report a case of a 50-year-old female on pravastatin therapy for 3 d prior to developing symptoms of AP. The common etiological factors for AP were all excluded. The patient was admitted to the intensive care unit secondary to respiratory distress, though she subsequently improved and was discharged 14 d after admission. Although the incidence of drug-induced AP is low, clinicians should have a high index of suspicion for it in patients with AP due to an unknown etiology. Clinicians should be aware of the association of statins with AP. If a patient taking a statin develops abdominal pain, clinicians should consider the diagnosis of AP and conduct the appropriate laboratory and diagnostic evaluation if indicated.


Subject(s)
Anticholesteremic Agents/adverse effects , Pancreatitis/chemically induced , Pravastatin/adverse effects , Acute Disease , Anticholesteremic Agents/therapeutic use , Female , Humans , Hypercholesterolemia/drug therapy , Hypercholesterolemia/physiopathology , Middle Aged , Pancreatitis/diagnosis , Pancreatitis/physiopathology , Pravastatin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...